ENZ : Summary for Enzo Biochem, Inc. ($0.01 Par - Yahoo Finance

U.S. Markets closed

Enzo Biochem, Inc. (ENZ)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
8.80+0.06 (+0.69%)
At close: 4:02PM EDT
People also watch
ENZNARQLAMRIIMMUMYGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close8.74
Open8.75
Bid8.75 x 100
Ask8.85 x 100
Day's Range8.70 - 8.85
52 Week Range4.76 - 8.98
Volume159,699
Avg. Volume213,998
Market Cap407.37M
Beta1.06
PE Ratio (TTM)12.92
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube2 days ago

    ETFs with exposure to Enzo Biochem, Inc. : April 27, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Enzo Biochem, Inc. Here are 5 ETFs with the largest exposure to ENZ-US. Comparing the performance and risk of Enzo Biochem, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Business Wire12 days ago

    Enzo Biochem’s Clinical Laboratory Named an In-Network Provider to the Fourth Largest National Insurer

    Enzo Biochem, Inc. announced today that its Enzo Clinical Laboratory subsidiary, a full-service clinical laboratory with a specialty in women’s health, today reached an agreement with the nation's fourth largest health insurer to become an in-network provider serving all states with its advanced laboratory testing services.

  • Illumina (ILMN) Launches VeriSeq NIPT Solution in Europe
    Zacks16 days ago

    Illumina (ILMN) Launches VeriSeq NIPT Solution in Europe

    Illumina, Inc. (ILMN) recently announced the launch of a solution pertaining to its noninvasive prenatal testing (NIPT) range in Europe.